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Protein phosphorylationThe soluble adenylyl cyclase (sAC) catalyzes the conversion of ATP into cyclic AMP (cAMP). Recent studies have
shed new light on the role of sAC localized in mitochondria and its product cAMP, which drives mitochondrial
protein phosphorylation and regulation of the oxidative phosphorylation system and other metabolic enzymes,
presumably through the activation of intra-mitochondrial PKA. In this review article, we summarize recent
ﬁndings on mitochondrial sAC activation by bicarbonate (HCO3−) and calcium (Ca2+) and the effects on
mitochondrial metabolism.We also discuss putative mechanismswhereby sAC-mediatedmitochondrial protein
phosphorylation regulates mitochondrial metabolism. This article is part of a Special Issue entitled: The role of
soluble adenylyl cyclase in health and disease.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
In 1975, Braun and Dods described for the ﬁrst time the presence in
the cytosol of a “soluble” adenylyl cyclase (sAC), distinct from the trans-
membrane adenylyl cyclase (tmAC), which could be stimulated by
Mn2+ and potentiated by calcium (Ca2+). These initial ﬁndings were
made in rat seminiferous tubules and epididymal sperm [1,2]. Indeed,
the gene encoding for sAC is highly expressed in testis, where the pro-
tein mostly consists of a shorter fragment (48 kDa) of the full-length
sAC (187 kDa) [3]. Functionally sAC is a cyclase that converts ATP in
cyclic AMP (cAMP), the ubiquitous second messenger responsible for
many signaling cascades in the cells. The presence of a soluble form of
adenylyl cyclase allows cAMP to be produced in deﬁned subcellular
compartments, where it serves local signaling functions [3]. The catalyt-
ic active portions of sAC (C1 and C2) are conserved in cyanobacteria and
myxobacteria, suggesting an evolutionary continuity, between the
bacterial and mammalian sAC–cAMP signaling systems.
The enzymatic activity of sAC can be directly stimulated bybicarbon-
ate (HCO3−) in vivo and in vitro [4] and by Ca2+, in a concentration
dependent manner [5,6]. Furthermore, it has been shown that sAC
reﬂects alterations in intracellular ATP ﬂuctuation in HEK293 cells [7].
Taken together, these ﬁndings suggest that sAC can be considered as a
putative metabolic sensor. Recently the crystal structure of the human
sAC apo state was described [8,9], including the mechanism of catalysise of soluble adenylyl cyclase in
stitute, Weill Medical College of
Y 10065, USA. Tel.:+1 646 962
di).and the binding site of the HCO3− activation and regulators. The struc-
ture shows how HCO3− binds and activates sAC and how sAC can be
inhibited by a drug [8,9].
sAC was shown to localize to various subcellular compartments,
including mitochondria, centrioles, mitotic spindles, mid-bodies and
nuclei [10], suggesting that each one of these cell compartments con-
tains a cAMP target. In particular, the role of sAC inmitochondria started
to emerge in the recent years. Several laboratories have demonstrated
that cAMP is generated in the mitochondrial matrix, where it regulates
mitochondrial metabolism, coupling the CO2 generation in the Krebs
cycle with the activity of the oxidative phosphorylation machinery
[11–13]. It needs to be noted, however, that sAC and PKA, as well as
thephosphodiesterase PDE2, are not reported in theMitoCarta compen-
dium of the mitochondrial proteome [14]. The lack of predicted mito-
chondrial localization on the basis of canonical import signals in the
primary protein sequences suggests that sAC and PKA enter mitochon-
dria through alternative, still poorly understood, mechanisms. Alterna-
tively, there could be unidentiﬁed splice isoforms with mitochondrial
targeting. In the following sections, some of the issues raised around
the presence of these proteins in mitochondria will be discussed in
more detail.
Once generated by sAC, cAMP inside the cell stimulates its cellular
effector protein kinase A (PKA) responsible for protein phosphorylation.
In mitochondria, the activity of many enzymes and carriers is modulat-
ed by phosphorylation [15,16]. The mechanisms underlying the regula-
tion of these post-translational modiﬁcations are emerging, but are
yet to be described in complete detail. Our current understanding of
this process is based on the evidence that cAMP is locally produced
inside mitochondria by sAC, where it activates a kinase, presumably
PKA, which then phosphorylates mitochondrial proteins, thereby
regulating their function [12,17,18]. Here, we review and discuss
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role of sAC-generated cAMP in mitochondria in the regulation of
energy metabolism.
1.1. sAC localization in mitochondria
The ﬁrst evidence that sAC is localized inmitochondriawas shown in
COS7 cells stained with both αN-term and αC-term sAC antisera and
the mitochondrial marker MitoTracker green [10]. In this work, sAC
was also detected in mitochondria of cardiac and skeletal muscle.
Functionally, our group proposed for the ﬁrst time that cAMP contained
in the mitochondrial matrix is not generated in the cytosol and
transported across the inner membrane, as previously suggested [19],
because the latter is impermeant to cAMP. Instead, we showed that
matrix cAMP originated inside the mitochondria by the action of sAC,
in response to metabolically generated carbon dioxide [11]. Other
groups have conﬁrmed the presence of this signaling pathway in the
mitochondrialmatrix, using different approaches, such as cAMP speciﬁc
FRET sensors [12,18]. It was also shown that sAC activation increases
ATP production in cells and isolatedmitochondria [12,17]. The oxidative
phosphorylation (OXPHOS) activities, such as ATP production, O2 con-
sumption, and cytochrome oxidase (COX) activity, are decreased by
sAC inhibition, whereas sAC activation by HCO3− and Ca2+ stimulates
OXPHOS [12,17]. These authors concluded that the sAC–cAMP signaling
pathway represents a metabolic sensor that modulates OXPHOS and
ROS generation. Fig. 1 shows a schematic representation of the putative
sAC–cAMP signaling pathway in mitochondria (Fig. 1).
1.2. sAC regulation by HCO3
− in mitochondria
The role of sAC in energy metabolism started to emerge when the
sensitivity to HCO3− was discovered [4]. HEK293 cell line expressing
the full-length sAC cDNA accumulated cAMP upon sAC stimulation
with NaHCO3. On the contrary, tmsAC was insensitive to HCO3−. TheFig. 1. sAC–cAMP–PKA pathway in mitochondria. sAC converts ATP in cAMP, the ubiquitous se
(e.g. overexpression of themitochondrial calciumuniporter,MCU) andHCO3− originated from th
was proposed that cAMP activates PKA, leading to phosphorylation of the NDUFS4 subunit of co
subunit COXIV-1 of complex IV (blue line), leading to an increase in COX activity,membrane pot
noted that the evidence that PKA is the sAC effector in mitochondria is contradictory and oth
this involves the mitochondrial sAC-signaling pathway is still unknown. Furthermore, protein
and β-oxidation are also phosphorylated.latest is generated inside themitochondria via the action of the enzyme
carbonic anhydrase that coverts CO2 derived from the Krebs cycle. Our
group has investigated cAMP production in mouse liver isolated mito-
chondria in the presence of 30 mM HCO3−, which is in the range of the
physiological intra-mitochondrial HCO3− concentration. Under these
conditions, COX activity and ATP synthesis were signiﬁcantly increased
[11], indicating a stimulation of the OXPHOS system by cAMP gener-
ated within mitochondria. We noted that, since OXPHOS activity is
increased by both HCO3− and by exogenously generated CO2, in a car-
bonic anhydrase dependent manner, these effects could not be due
to pH changes (or ionic strength), because HCO3− addition increases,
while CO2 addition decreases the pH of the experimental medium,
which (because the ΔpH is constant) is followed by the pH of the
matrix [11].
Di Benedetto et al. recently showed that CHO cells transfected with
the cAMP sensor 4mtH30 targeted to mitochondria and treated with
50 mM NaHCO3 displayed a biphasic kinetic of cAMP generation, with
an initial rise followed by a plateau [12]. Cells pretreated with the sAC
inhibitor hydroxyl-estradiol and stimulated with HCO3− showed a
signiﬁcant decrease in cAMP generation. Taken together, these data
demonstrated a direct effect of HCO3− in activating sAC and cAMP pro-
duction in mitochondria.
1.3. sAC regulation by Ca2+ in mitochondria
Jaiswal et al. showed that sAC in the cytosol is regulated by Ca2+ in
mature human spermatozoa in a concentration dependent manner
(between 10−8 and 10−4 M). They also showed sAC regulation by
Ca2+ in HEK293 cells treated with a Ca2+ ionophore (which induces
Ca2+ inﬂux from the extracellular media) or carbachol (which recruits
Ca2+ from intracellular stores) [5]. The recent development of targeted
cAMP sensors [12,18] allowed for a better understanding of the cAMP
responses inside mitochondria and for the investigation of Ca2+ and
cAMP crosstalk in the regulation of energy metabolism.cond messenger, which is degraded by phosphodiesterase (PDE). sAC is activated by Ca2+
eCO2 derived from theKrebs cycle spontaneously or by the action of carbonic anhydrase. It
mplex I (CI, green line), thereby regulating CI activity. sAC also induces phosphorylation of
ential (Δψ), O2 consumption and ATP production,without altering ROS level. It needs to be
er kinases may be involved. Other OXPHOS complexes are phosphorylated, but whether
s related to TCA cycle, calcium homeostasis, apoptosis, transporters, fatty acid oxidation
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inside mitochondria using a mitochondrially targeted cAMP sensor
(4mtH30) properly targeted to themitochondria [12]. In order to assess
if Ca2+ could stimulate cAMP inside mitochondria, CHO cells were
transfected with 4mtH30, derived from CFP-Epac(δDEP-CD)-YFP probe
with a mitochondrial targeting signal added to its N-terminus [20].
Cytosolic Ca2+ increase from intracellular stores release, induced by
the IP3-generating agonist ATP in combination with the SERCA pump
inhibitor TBHQ, resulted in a marked increase in mitochondrial cAMP
signal, supporting the notion that Ca2+ stimulates sAC inside mitochon-
dria [12].
Overexpression of themitochondrial Ca2+ uniporter (MCU) leads to
an increase in mitochondrial Ca2+ accumulation [21,22]. Accordingly,
Di Benedetto et al. showed that overexpression of MCU resulted in an
increase in mitochondrial cAMP, while MCU silencing decreased mito-
chondrial cAMP [12]. Moreover, increased frequency and amplitude of
mitochondrial Ca2+ oscillations triggered an increase of matrix cAMP
in primary cultured neonatal rat cardiomyocytes transfected with
mtH30 sensor [12].
ATP production increases when sAC is overexpressed in cells. Di
Benedetto et al. demonstrated that ATP concentration increases in
mitochondria with targeted sAC expression (mtsAC cells) [12], using a
luciferase sensor, mtLUC, targeted to mitochondria [23]. Mitochondrial
ATP dynamics was measured upon Ca2+ stimulation in control and
mtsAC HeLa cells. Under this condition both the rate and the extent
of ATP concentration were upregulated, demonstrating that Ca2+
stimulated-ATP depends, at least in part, on sAC, as Ca2+ regulates
directly some of the Krebs cycle dehydrogenases, having per se a
stimulatory effect [24]. To further investigate if this mechanism is
PKA-dependent, a PKA inhibiting peptidewas targeted to themitochon-
dria (mt-PKI). The overexpression of mt-PKI induced a decrease in ATP
concentration in both control and mtsAC overexpressing cells. These
data conﬁrm that the target of mitochondrial cAMP is PKA or a PKA-
like kinase.
Taken together the work described above showed that Ca2+ modu-
lates components of the cAMP pathwaywithin mitochondria, including
sAC and PKA. It is certainly an interesting ﬁnding that the physiology of
the two major cell regulators Ca2+ and cAMP takes place inside the
mitochondria with an interconnected pathway [25].
1.4. sAC–cAMP effectors in mitochondria
A number of protein families have been identiﬁed as cAMP effectors
in mammalian cells. Upon cAMP binding, exchange proteins directly
activated by cAMP (Epac) 1 and 2 serve as guanine nucleotide exchange
factors for the small GTP-ases Rap1 and Rap2 [26,27]. A large family
of cyclic-nucleotide-activated ion channels have been described,
which can be divided into three major subgroups; hyperpolarization-
activated cyclic-nucleotide-modulated (HCN) channels, voltage inde-
pendent cyclic-nucleotide-gated (CNG) channels and K+ channels
called EAG and EAG-like channels; however, modulation of the latter
by cAMP is less well established [26].
The best understood regulatory effects of cAMP are mediated by
activation of the cAMP-dependent protein kinases (PKAs). PKA exists
primarily as an inactive tetrameric holoenzyme, consisting of two of
each catalytic (C) and regulatory (R) subunits. cAMP binding on the
regulatory subunits triggers the release of the active C subunits, which
then phosphorylate speciﬁc serine and threonine residues of target
proteins [28]. There is no single consensus sequence that predicts
phosphorylation sites; however, the Arg-Arg-X-Ser is common and
highly similar domains are contained within the vast majority of
known sites [29]. The cellular distribution of PKA largely depends on
the R subunit isoforms. Type IIα and IIβ are mostly bound to anchor
proteins, while type Iα and Iβ are considered being more diffusedly
cytosolic, but unspeciﬁc anchoring of both types (see below) and type
I speciﬁc anchor sites have also been described to play important rolesin signaling [30–33]. Depending on cell type and subcellular localization
of the enzyme, the cAMP dependent protein phosphorylation by PKA is
responsible for a wide variety of cellular responses [34–36]. Investiga-
tions of subcellular fractions revealed the existence of mitochondrial
protein phosphorylation activity [37,38] in different sub-mitochondrial
fractions [39]. Nevertheless, especially for the matrix compartment
the nature of the cAMP effector is controversial. The evidence both
supporting and undermining the idea of PKA being the effector of cAMP
in different mitochondrial compartments are reviewed below.
Evidence of A-kinase anchoring proteins (AKAPs) targeted to mito-
chondria may be a good indication that PKA is the effector of cAMP in
these organelles. AKAPs are often part of heterogeneous complexes to-
gether with the R subunit of PKA, including mRNAs, tyrosine phospha-
tase(s) and tyrosine kinase(s) [40]. Their role is the control of spatial
distribution and speciﬁcity of PKA activity throughout the cell, allowing
for efﬁcient transduction of the cAMP signal. The AKAP1 gene translates
into several splice variants, of which three were found to be associated
to mitochondria. Both S-AKAP 84 [41] and AKAP 121 [42] bind RII sub-
units, while D-AKAP1 [43] binds both RI and RII; furthermore, all three
variants share a targeting sequence on their N terminals, directing
them to the outer mitochondrial membrane (OMM). AKAP 121 was
also demonstrated to be present in the matrix by immunoelectron
microscopy [44] and to regulate oxidative phosphorylation through
COX [45]. Other AKAPs, such as D-AKAP2, co-localize with cytochrome
c upon immunostaining [46]. The mechanism by which D-AKAP2 is
targeted to mitochondria is still unclear. Recently, it was also shown
that AKAP79, known to be associated to the plasma membrane and
lacking amitochondrial targeting sequence [47], is present inmitochon-
dria isolated from human placenta [48]. Finally, two proteins were
discovered to act as AKAPs, as a secondary function. The Rab subfamily
of Ras proteins regulates membrane dynamics upon activation by GTP.
Rab 32, uniquely in the subfamily, is an important player in mitochon-
drial ﬁssion and also binds PKA [49]. The sphingosine kinase interacting
protein (SKIP), which interestingly speciﬁcally binds the RI (mostly
cytosolic) subunit, was shown to be present in the intermembrane
space (IMS) and the mitochondrial matrix [50,51].
Although a few of the AKAPsmentioned abovewere reported also in
themitochondrialmatrix, evidence best supports that they are associat-
ed to the cytosolic surface and IMS of mitochondria, where small
molecules of the cytosol can diffusewithout constraint; therefore, theo-
retically both tmAC and sAC can produce cAMP affecting PKA in these
domains. In the mitochondrial matrix however, sAC is the only source
of cAMP described to date. There are numerous reports of matrix PKA
activity revealed by protein phosphorylation upon radiolabeling [39,
52–60], by immunoblotting and immunocytochemistry [44,61] and
by immuno-electron microscopy [62]. Sardanelli et al. estimated that
~90% of total mitochondrial PKA activity was present in the matrix
[44]. More recently, a novel method to assess PKA activity speciﬁcally
was developed by applying coumarin-derived ﬂuorescent peptides as
PKA substrates [63]. In this work, the relative PKA activities of the
outer surface, IMS and matrix of isolated bovine heart mitochondria
were measured to be 9:6:85 percent, respectively. Our group was the
ﬁrst to examine the impact of pharmacological effectors of PKAonmito-
chondrial parameters, and found that oxidative phosphorylation was
activated by the agonist 8Br-cAMP; and inactivated by inhibitors (H89,
myristoylated PKI) of PKA,while 8CPTmethyl-cAMP, a speciﬁc activator
of Epac had no effect [11]. The inhibitory effects of H89, PKI and addi-
tionally Rp-8-CPT-cAMP on matrix ATP levels were conﬁrmed by Di
Benedetto et al.; however, they did not achieve activation of matrix
ATP by 8Br-cAMP or 8-CPT-6-Phe-cAMP [12]. It is worth to note, that
matrix ATP concentration is only one of the numerous factors that
contribute to the regulation of the kinetics of ATP production in mito-
chondria [64], andmay verywell not be the only one affected by protein
phosphorylation; furthermore, elevated matrix ATP may not always
correlate with elevated ATP output through the adenine nucleotide
translocase [65].
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targeting sequences undermines the idea of their presence in the
matrix. Di Benedetto et al. reported failure to showmitochondrial local-
ization of GFP tagged PKA subunits (unpublished results in [25]).
Furthermore, PKA activity could not be measured by matrix targeted
A-kinase activity reporter (AKAR) 3 and 4 [18]. AKARs are FRET based
sensors containing a PKA speciﬁc substrate, which upon phosphoryla-
tion, due to conformational changes, increase their energy transfer
[66,67]. To conﬁrm that the negative result was not due to the sensor,
AKAR 4 was shown to respond to genetically engineered PKA targeted
to the matrix, which could be inhibited by co-expression of mito-PKI.
These results suggest that a yet undiscovered cAMP effector exhibiting
PKA-like responses to pharmacologicalmanipulation could be responsi-
ble for phosphorylation events in themitochondrialmatrix, as proposed
by Di Benedetto et al. [25]. Fig. 2 summarizes the genetically encoded
probes to study the function of sAC–cAMP–PKA inside mitochondria
(Fig. 2), as reported in recent publications by Di Benedetto and
Lefkimmiatis [12,18].1.5. Degradation of cAMP in mitochondria
In order for an autonomous cAMP signaling cascade to operate
properly inmitochondria,mechanisms for degrading the cAMPgenerat-
ed by sAC must also exist. Phosphodiesterase (PDE) activity, indicated
by cAMP hydrolyzing activity in the matrix, which was sensitive to a
non-selective PDE inhibitor, IBMX, was ﬁrst reported in mitochondria
along with the presence of sAC [11]. More recently, isolated mouse
brain and liver mitochondria were shown to lose cAMP and cGMP hy-
drolysis, when treated with BAY 60, an inhibitor of the PDE2A isoform.
The mitochondrial localization of the second splice variant of PDE2A
to the mitochondrial matrix was also demonstrated [68,69]. The inhibi-
tion of PDE2A increases oxygen consumption and ATP production in
isolated mitochondria [68]. Hydrogen sulﬁde at low levels was pro-
posed as a physiological effector of PDE2A in mitochondria [69].
These ﬁndings may offer new intriguing approaches in the treatment
of a wide variety of afﬂictions, in which bioenergetic incompetenceFig. 2.Genetically-encoded tools to study themitochondrial sAC–cAMP pathway. Recently, new
The diagram schematically depicts the genetically encoded probes. To detect cAMP in thematri
adding4 copies of themitochondrial targeting sequence of subunit VIII of thehuman cytochrom
to target AKAR3 and AKAR4, the FRET-based sensor to measure PKA activity, and PKI-mCherry
the OMM the targeting peptide used was yTom70 [18].contributes to pathology, by developing speciﬁc and safe inhibitors of
mitochondrial PDE2A2.
1.6. Mitochondrial phosphoproteins and metabolism
Phosphorylation represents an important regulatory mechanism
for mitochondrial protein function. In particular, as discussed above,
reversible phosphorylation of mitochondrial proteins is a player in
OXPHOS modulation. Many mitochondrial proteins are known to be
phosphorylated [16,70–74], but the relation between phosphorylation
and function is still not completely understood.
Contrasting results suggest that phosphorylation by PKA can both
inhibit and activate OXPHOS. Papa et al. demonstrated that the
NDUFS4 accessory subunit of complex I (CI) is phosphorylated by PKA
(Fig. 1). Patients harboring mutation in this subunit displayed decrease
CI activity and decreased cAMP-dependent phosphorylation [75,76].
Bender and Kandenbach showed that the allosteric ATP inhibition of
CIV in bovine heart is switched on by cAMP dependent phosphorylation
of sub II and Vb by PKA, and switched off by protein phosphatase 1 [77].
Moreover, the cytochrome c oxidase results in a serine and threonine
phosphorylation via PKA of subunit I, whichwas correlatedwith inhibi-
tion of the enzyme in the presence of ATP [78]. Our group proposed that
PKA phosphorylates COXIV-I at serine 58 and enhances COX activi-
ty [79]. This COX regulation by phosphorylation of COXIV-1 subunit
was due to prevention of COX allosteric inhibition by ATP (Fig. 1).
Furthermore, overexpression of sAC targeted to the mitochondrial ma-
trix of COXIV-I deﬁcient cells dramatically improved mitochondrial
function and stabilized a long-term metabolic adaptation. This was
interpreted as the result of constitutive stimulation of cAMP production
in mitochondria triggering adaptation mechanisms in COX deﬁcient
cells, which upregulated OXPHOS function and reduced the need for
enhanced ROS-dependent OXPHOS biogenesis [79]. In a therapeutic
perspective, mitochondrial sAC activation or cAMP degradation inhibi-
tion in COX deﬁcient cells could be a viable strategy to improve
COX deﬁciency in vivo [17].
Recent work investigated the correlation between phosphorylation
and function in mitochondria from mouse liver and human skeletaltools were developed to investigate themitochondrial sAC–cAMP pathway in living cells.
x H30 and H90were targeted to themitochondria matrix (4mtH30 andmito-EpacH90) by
e oxidase (COX8) at theN-terminus of the Epac1-cAMP sensor. The same strategywasused
(mt-PKI) and PKA-Cat-mCherry to thematrix [12,18]. To target PKA, AKAR3 and AKAR4 to
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but also metabolism related proteins indirectly connected with
mitochondria. However, their relation with sAC-PKA remains unknown
so far. Grimsrud et al. reveled that phosphorylation is a key mechanism
in regulating ketogenesis (phosphorylation of Serine 456 on Hmgcs2)
in obese and type 2 diabetes mice [80]. The acute mitochondria phos-
phorylation changes during fasting and re-feeding of mice. Together,
these data show that Hmgcs2 S456, the enzyme that catalyzes the
rate-limiting step in ketogenesis, is an important phosphorylation tar-
get, which enhances enzymatic activity during increased ketogenic
demand.
Phosphorylationwas shown in human skeletalmusclemitochondri-
al proteins involved in oxidative phosphorylation, TCA cycle, lipid me-
tabolism, amino acid degradation, importers and transporters, calcium
homeostasis, and apoptosis (Fig. 1) [73]. Using different phosphopep-
tide enrichment techniques and mass spectrometry, Zhao et al. identi-
ﬁed 176 different phosphorylation sites in 86 mitochondrial proteins.
The major proportion of the identiﬁed phospho-sites involves potential
substrates of PKA, but also CKII, PKC or DNAPK. PKA activity has been
shown in human mitochondria [15,81] regulating protein expression,
biogenesis and apoptosis. As discussed above, the presence of PKA in
mitochondria is still controversial. Detection of mitochondrial protein
kinases is difﬁcult due to their concentration relative to proteins. More-
over, the lack of a highly speciﬁc antibody and possible contamination
from associated cell compartments limit the possibility of clearly
dissecting the nature of the kinases involved [82].1.7. Conclusions and future perspectives
The discovery of sACwithin themitochondria opens new avenues to
study metabolic regulation dependent on HCO3− and Ca2+ stimulation
via the sAC–cAMP pathway. It needs to be noted, however, that the
studies of sAC function in mitochondria described above were conduct-
ed only in cell culture models or isolated mitochondria. Currently, there
is nohard evidence on the relation between sAC function,mitochondrial
protein phosphorylation, andmetabolic regulation in vivo. Two different
mouse models of sAC deletion are available [83,84]. In the ﬁrst one, the
catalytic domain C1 was knocked out (sAC C1KO), whereas in the sec-
ond the C2 catalytic domain was abolished. Investigatingmitochondrial
function and protein phosphorylation in different tissues of these mice
will shed new lights on the functions of sAC in mitochondria in vivo.
Therefore, different approaches will need to be devised to speciﬁcally
investigate the intra-mitochondrial effects of sAC modulation. Since
total sAC KO will likely affect extra-mitochondrial function that may
indirectly affect mitochondrial metabolism, models where sAC is
exclusively depleted or increased in mitochondria would be very useful
for a better understanding of mitochondrial and metabolic regulation.
In addition, more work is necessary to investigate the effect of sAC
on OXPHOS complexes and TCA cycle, fatty acid transporters, beta
oxidation, amino acid degradation, calcium homeostasis, etc., [73]
in vitro and in vivounder different relevant conditions that affectmetab-
olism, such as high and low calorie intake or exposure to cold or in
conditions where the energy metabolism is compromised by aging or
disease. Such studies could provide insights on the potential signiﬁ-
cance of modulating sAC and cAMP in mitochondria as a therapeutic
tool for metabolic and degenerative diseases that affect metabolism.References
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